Cell Type-Specific Adenoviral Transgene Expression in the Intact Ovine Pituitary Gland after Stereotaxic Delivery: An in VivoSystem for Long-Term Multiple Parameter Evaluation of Human Pituitary Gene Therapy**This work was supported by the Medical Research Council, the Biotechnology and Biological S

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Endocrinology

• Publication date

  2001-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1210/endo.142.2.7963PMID 28204461
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Gene Therapy for Pituitary Tumors

  2003cited by this paper
• Stereotactic injection of adenoviral vectors that target gene expression to specific pituitary cell types: implications for gene therapy.

  2000cited by this paper
• Adenovirus-mediated herpes simplex virus type-1 thymidine kinase gene therapy suppresses oestrogen-induced pituitary prolactinomas.

  2000cited by this paper
• Central nervous system toxicity of two adenoviral vectors encoding variants of the herpes simplex virus type 1 thymidine kinase: reduced cytotoxicity of a truncated HSV1-TK

  2000cited by this paper
• Gene therapy strategies for the treatment of pituitary tumours.

  1999cited by this paper
• High efficiency method for gene transfer in normal pituitary gonadotropes: adenoviral-mediated expression of G protein-coupled receptor kinase 2 suppresses luteinizing hormone secretion.

  1999cited by this paper
• Cell-type specific expression in the pituitary: physiology and gene therapy.

  1999cited by this paper
• Targeted expression of toxic genes directed by pituitary hormone promoters: a potential strategy for adenovirus-mediated gene therapy of pituitary tumors.

  1999cited by this paper
• Outcome of transphenoidal surgery for acromegaly and its relationship to surgical experience

  1999cited by this paper
• Chronic brain inflammation and persistent herpes simplex virus 1 thymidine kinase expression in survivors of syngeneic glioma treated by adenovirus-mediated gene therapy: Implications for clinical trials

  1999cited by this paper
• Switching transgene expression in the brain using an adenoviral tetracycline-regulatable system

  1998cited by this paper
• Multistep signaling requirements for pituitary organogenesis in vivo.

  1998cited by this paper
• The cytogenesis and pathogenesis of pituitary adenomas.

  1998cited by this paper
• Detection of prolactin receptor gene expression in the sheep pituitary gland and visualization of the specific translation of the signal in gonadotrophs.

  1998cited by this paper
• Dynamic changes in prolactin promoter activation in individual living lactotrophic cells.

  1998cited by this paper
• The Case for Initial Surgical Removal of Certain Prolactinomas

  1997cited by this paper
• Expression of transgenes in normal and neoplastic anterior pituitary cells using recombinant adenoviruses: long term expression, cell cycle dependency, and effects on hormone secretion.

  1997cited by this paper
• Adenovirus-mediated inducible gene expression through tetracycline-controllable transactivator with nuclear localization signal.

  1997cited by this paper
• The outcome of hypophysectomy for prolactinomas in the era of dopamine agonist therapy

  1996cited by this paper
• Suppression of pulsatile luteinizing hormone secretion by gonadotrophin-releasing hormone antagonist does not affect episodic progesterone secretion or corpus luteum function in ewes.

  1992cited by this paper
• Encephalic ventricles of the ewe (Ovis aries L.): conformation, relations and stereotaxic topography.

  1991cited by this paper
• Multihormonal regulation of the human prolactin gene expression from 5000 bp of its upstream sequence.

  1991cited by this paper
• Pit-1 binding sequences permit calcium regulation of human prolactin gene expression.

  1991cited by this paper
• Stereotaxic approach to hypothalamic nuclei of the Shiba goat with radiographic monitoring.

  1990cited by this paper
• Regulatory elements controlling pituitary-specific expression of the human prolactin gene

  1990cited by this paper
• Hypopituitarism following external radiotherapy for pituitary tumours in adults.

  1989cited by this paper
• Effect of chronic immunoneutralization of thyrotropin-releasing hormone on the hypothalamic-pituitary-thyroid axis, prolactin, and reproductive function in the ewe.

  1982cited by this paper
• Effect of suppression of plasma prolactin on ovulation, plasma gonadotrophins and corpus luteum function in LH-RH-treated anoestrous ewes.

  1979cited by this paper
• Printed in U.S.A. Copyright © 2000 by The Endocrine Society Transcriptional Targeting to Anterior Pituitary

  year unknowncited by this paper

• Real-time visualization of human prolactin alternate promoter usage in vivo using a double-transgenic rat model.

  2009cites this paper
• Improvement in reproductive parameters in hypogonadal female mice by regulated gene replacement therapy in the central nervous system

  2007cites this paper
• Advances in the treatment of prolactinomas.

  2006cites this paper
• Neuronal expression of the transcription factor Gli1 using the Tα1 α-tubulin promoter is neuroprotective in an experimental model of Parkinson's disease

  2004cites this paper
• Tumores hipofisários: opções terapêuticas atuais e perspectivas futuras de tratamento

  2003cites this paper
• Is pituitary gene therapy realistic?

  2001cites this paper
• Editorial: Pituitary Gene Therapy-Hypotheses on the Hypophysis.

  2001cites this paper